Q Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2004-01-01
- Employees
- 10
- Market Cap
- -
- Website
- http://www.qthera.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis
Phase 1
Recruiting
- Conditions
- Transverse Myelitis
- First Posted Date
- 2019-03-22
- Last Posted Date
- 2023-08-21
- Lead Sponsor
- Q Therapeutics, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT03887273
- Locations
- 🇺🇸
UT Southwestern, Dallas, Texas, United States
Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 1
Not yet recruiting
- Conditions
- Amyotrophic Lateral Sclerosis
- First Posted Date
- 2015-06-23
- Last Posted Date
- 2023-08-21
- Lead Sponsor
- Q Therapeutics, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02478450
News
No news found